Empagliflozin protects against doxorubicin-induced arrhythmia by AMPK/mTOR-mediated autophagy in cardiomyocyte. Liu HY, Lv YD, Chen YQ, Dai C, et al. Eur J Pharmacol 2026;1014:178520.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu HY, Lv YD, Chen YQ, Dai C, et al. Empagliflozin protects against doxorubicin-induced arrhythmia by AMPK/mTOR-mediated autophagy in cardiomyocyte. Eur J Pharmacol 2026;1014:178520.
PMID: 41512919